Moody's elevates Aegis Toxicology

Moody's Investors Service said it upgraded Aegis Toxicology Sciences Corp.’s ratings, including its corporate family rating to B3 from Caa1 and its probability of default rating to B3-PD from Caa1-PD.

Moody's also upgraded the senior secured first-lien rating to B3 from Caa1.

The rating agency changed the outlook to stable from negative.

“The upgrade of the CFR reflects a material improvement in Aegis's liquidity and cash flow following a significant improvement in operating performance in 2020,” Moody’s said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.